13 November 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on nine medicines.

Selpercatinib (Retsevmo) was accepted on an interim basis for the treatment of a rare type of non-small-cell lung cancer.

Read SMC press release